Geneva Advisors’s CHS Inc Class B Series 4 Preferred Stock CHSCL Stock Holding History

Geneva Advisors’s Portfolio CHSCL Stock Details CHSCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$318K	Hold	11,000	–	–	0.01%	597
2017 Q1	$316K	Sell	11,000 -850	-7%	-$23.9K	0.01%	583
2016 Q4	$322K	Sell	11,850 -308	-3%	-$8.64K	0.01%	563
2016 Q3	$359K	Buy	12,158 +158	+1%	+$4.73K	0.01%	538
2016 Q2	$345K	Hold	12,000	–	–	0.01%	527
2016 Q1	$334K	Hold	12,000	–	–	0.01%	521
2015 Q4	$325K	Sell	12,000 -2,000	-14%	-$54.8K	0.01%	484
2015 Q3	$371K	Hold	14,000	–	–	0.01%	438
2015 Q2	$379K	Buy	14,000 +1,000	+8%	+$27.6K	0.01%	480
2015 Q1	$360K	Buy	+13,000	New	+$348K	0.01%	476

Other funds holding CHSCL

KIA

KCM Investment Advisors Greenbrae, California $3.01B AUM 21.97% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Geneva Advisors's CHSCL Position: Q2 2017 in Review

Geneva Advisors held its CHS Inc Class B Series 4 Preferred Stock (CHSCL) position steady in Q2 2017 at 11,000 shares worth $318K. The position accounts for 0.01% of the portfolio, ranked #597.

Geneva Advisors first reported a position in CHSCL in Q1 2015 and has held it in 10 quarters since. The position peaked at $379K in Q2 2015. 3 funds tracked by Wall St. Rank hold CHSCL as of Q2 2017.

Geneva Advisors held 11,000 shares of CHS Inc Class B Series 4 Preferred Stock worth $318K as of Q2 2017.
Geneva Advisors left its CHS Inc Class B Series 4 Preferred Stock share count unchanged in Q2 2017.
CHS Inc Class B Series 4 Preferred Stock made up 0.01% of Geneva Advisors's portfolio in Q2 2017, its #597 holding.
Geneva Advisors first reported a position in CHS Inc Class B Series 4 Preferred Stock in Q1 2015 and has held it in 10 quarters since.
Geneva Advisors's CHS Inc Class B Series 4 Preferred Stock position peaked at $379K in Q2 2015.
3 funds tracked by Wall St. Rank held CHS Inc Class B Series 4 Preferred Stock as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.